Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque. (Q45307020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Charles W. Wilkinson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

10

Suzanne Craft

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

J Jacob Kulstad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Pamela J McMillan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

David G Cook

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Pattie S Green

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Elaine R Peskind

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wesley Farris

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Pankaj D Mehta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuropathology & Experimental Neurology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

139-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15751228%20AND%20SRC:MED&resulttype=core&format=json

Insulin degradation: progress and potential

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Cortisol and Alzheimer's disease, I: Basal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Elevated urinary free cortisol in patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Increased CSF cortisol in AD is a function of APOE genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Mechanisms of dexamethasone-induced insulin resistance in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Glucocorticoids and insulin resistance: old hormones, new targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Clearing amyloid through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F64.2.139